A detailed history of Hardy Reed LLC transactions in Medpace Holdings, Inc. stock. As of the latest transaction made, Hardy Reed LLC holds 737 shares of MEDP stock, worth $256,829. This represents 0.02% of its overall portfolio holdings.

Number of Shares
737
Previous 737 -0.0%
Holding current value
$256,829
Previous $303,000 19.14%
% of portfolio
0.02%
Previous 0.03%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

SELL
$372.0 - $424.34 $48,360 - $55,164
-130 Reduced 14.99%
737 $303,000
Q1 2024

May 02, 2024

SELL
$284.87 - $413.31 $47,288 - $68,609
-166 Reduced 16.07%
867 $350,000
Q4 2023

Jan 24, 2024

SELL
$227.52 - $312.68 $1,137 - $1,563
-5 Reduced 0.48%
1,033 $316,000
Q2 2023

Aug 14, 2023

BUY
$187.26 - $240.17 $194,375 - $249,296
1,038 New
1,038 $249,000
Q1 2022

Apr 28, 2022

BUY
$138.87 - $214.31 $114,845 - $177,234
827 New
827 $135,000

Others Institutions Holding MEDP

About Medpace Holdings, Inc.


  • Ticker MEDP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 31,099,900
  • Market Cap $10.8B
  • Description
  • Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...
More about MEDP
Track This Portfolio

Track Hardy Reed LLC Portfolio

Follow Hardy Reed LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hardy Reed LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hardy Reed LLC with notifications on news.